Dynamic 99mTc-Tetrofosmin CZT-SPECT Myocardial Perfusion Imaging in Comparison With Fractional Flow Reserve in Patients After ST-elevation Myocardial Infarction - Trial NCT05940285
Access comprehensive clinical trial information for NCT05940285 through Pure Global AI's free database. This phase not specified trial is sponsored by Nantes University Hospital and is currently Not yet recruiting. The study focuses on Myocardial Infarction. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Nantes University Hospital
Timeline & Enrollment
N/A
Sep 01, 2023
Sep 01, 2026
Primary Outcome
Sensitivity, specificity, predictive positive value, negative predictive value, accuracy of MFR in comparison with FFR
Summary
Dynamic 99mTc-Tetrofosmin CZT-SPECT myocardial perfusion imaging (MPI) is an advanced
 functional imaging technique giving important myocardial flow quantification added data in
 comparison with conventional MPI, especially in coronary multi vessel disease. A large-scale
 validation of diagnostic performances of myocardial flow reserve (MFR) estimated with Dynamic
 99mTc-Tetrofosmin CZT-SPECT MPI would allow a non-invasive approach instead of invasive
 intra-coronary fractional flow reserve (FFR) measurement. The aim of this prospective study
 is to assess diagnostic performances of MFR calculated with dynamic 99mTc-Tetrofosmin
 CZT-SPECT MPI in comparison with invasive intra-coronary FFR measurement in patients with
 significant residual coronary arteries stenosis after ST-elevation myocardial infarction.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05940285
Non-Device Trial